Among the genes we selected to construct the Riskscore model, SLC1A1 [35], FZD1 [36], and SALL1 [37] were downregulated in ccRCC, while MALAT1 [38] was upregulated; there are specific clinical trials to verify their relationship with ccRCC. This evidence concerns the gene MALAT1 and nonpapillary renal cell carcinoma.